The latest from TV, Radio, and Newspapers

Add a news source

Are we missing a Burlington news source? Let us know!

Burlington Newswire

Comprehensive Real-Time News Feed for Burlington, MA.

Results 1 - 1 of 1 for "" in Burlington, MA

  1. Report: Current Symptomatic Agents Will Remain Mainstays of Alzheimer's Treatment Through 2021Read the original story

    Aug 4, 2013 | P&T Community

    Decision Resources, a research and advisory firm based in Burlington, Mass., reports that, through 2021, the key driver of growth in the Alzheimer's disease drug market will be the launch of two premium-priced disease-modifying agents - the anti-beta-amyloid monoclonal antibody solanezumab and the intravenous immune globulin product Gammagard . The company forecasts that solanezumab will be the first disease-modifying therapy to launch for AD in the major pharmaceutical markets - the U.S., the U.K., France, Germany, Italy, Spain, and Japan - and will attain "blockbuster" status in its first full year on the market, largely because of its substantial price premium over current agents.


Burlington Job Listings
View or post Burlington job listings on Topix.
Burlington Real Estate
News, listings, and foreclosures in Burlington from Topix.
Burlington Mortgages
Find mortgage rates in Burlington on Topix.